Journal for ImmunoTherapy of Cancer (Jun 2022)
Genome-scale CRISPR–Cas9 screen reveals novel regulators of B7-H3 in tumor cells
- Hui Yang,
- Gang Guo,
- Min Mu,
- Xi Zheng,
- Yuelong Wang,
- Ting Cao,
- Shasha Zhao,
- Cheng Huang,
- Xin Tang,
- Guoqing Wang,
- Nian Yang,
- Zhiguo Wu,
- Hexian Li,
- Kunhong Zhong,
- Zongliang Zhang,
- Meijun Zheng,
- Chunlai Nie,
- Liangxue Zhou,
- Aiping Tong
Affiliations
- Hui Yang
- Key Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution (Wannan Medical College), Wuhu, China
- Gang Guo
- Aff1 grid.410427.40000000419370183Department of Biochemistry and Molecular BiologyGeorgia Regents University Augusta GA USA
- Min Mu
- 2 Department of Public Health, School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China
- Xi Zheng
- 1Second Affiliated Hospital, and the Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Zhejiang University College of Medicine, China
- Yuelong Wang
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- Ting Cao
- Lab of Infectious Diseases and Vaccine, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- Shasha Zhao
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China
- Cheng Huang
- 1Department of Global Health, George Washington University, Washington, District of Columbia, USA
- Xin Tang
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- Guoqing Wang
- Department of Neurology, Bin zhou People`s Hospital, Binzhou, Shandong, China
- Nian Yang
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China
- Zhiguo Wu
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China
- Hexian Li
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China
- Kunhong Zhong
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China
- Zongliang Zhang
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China
- Meijun Zheng
- Department of Otolaryngology, Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- Chunlai Nie
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China
- Liangxue Zhou
- Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- Aiping Tong
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu, Sichuan, China
- DOI
- https://doi.org/10.1136/jitc-2022-004875
- Journal volume & issue
-
Vol. 10,
no. 6
Abstract
No abstracts available.